Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 139, Issue 5, Pages 1129-1139
Publisher
Wiley
Online
2016-04-13
DOI
10.1002/ijc.30138
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The immune response in cancer: from immunology to pathology to immunotherapy
- (2015) Nicolas A. Giraldo et al. VIRCHOWS ARCHIV
- Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer
- (2014) X Wang et al. BRITISH JOURNAL OF CANCER
- B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
- (2014) Nesrine I. Affara et al. CANCER CELL
- B Cells and Ectopic Follicular Structures: Novel Players in Anti-Tumor Programming with Prognostic Power for Patients with Metastatic Colorectal Cancer
- (2014) Anastasia Meshcheryakova et al. PLoS One
- The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
- (2013) Z M A Mohammed et al. BRITISH JOURNAL OF CANCER
- The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer
- (2013) Miriam Lohr et al. CANCER LETTERS
- Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma
- (2013) J.-Y. Shi et al. CLINICAL CANCER RESEARCH
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer
- (2013) Yunmei Liao et al. MEDICAL ONCOLOGY
- Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
- (2013) Sakarias Wangefjord et al. Biology of Sex Differences
- Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
- (2012) Arcadi Cipponi et al. CANCER RESEARCH
- A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin C as a Compatible Prognostic Marker in Human Solid Tumors
- (2012) M. Schmidt et al. CLINICAL CANCER RESEARCH
- CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
- (2012) J. S. Nielsen et al. CLINICAL CANCER RESEARCH
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
- (2012) Thomas J. Lynch et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer
- (2012) Zonglin Chen et al. PLoS One
- Immunoglobulin kappa chain as an immunologic biomarker of prognosis and chemotherapy response in solid tumors
- (2012) Marcus Schmidt et al. OncoImmunology
- The prognostic significance of B lymphocytes in invasive carcinoma of the breast
- (2011) S. M. A. Mahmoud et al. BREAST CANCER RESEARCH AND TREATMENT
- Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
- (2011) A Larsson et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study
- (2011) Sakarias Wangefjord et al. Biology of Sex Differences
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Clinical Relevance of Microsatellite Instability in Colorectal Cancer
- (2010) Albert de la Chapelle et al. JOURNAL OF CLINICAL ONCOLOGY
- B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice
- (2010) D. J. DiLillo et al. JOURNAL OF IMMUNOLOGY
- Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model
- (2009) S Julien et al. BRITISH JOURNAL OF CANCER
- Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
- (2009) Katy Milne et al. PLoS One
- The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CANCER RESEARCH
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non-Small Cell Lung Cancer
- (2008) K. I. Al-Shibli et al. CLINICAL CANCER RESEARCH
- Immune surveillance: a balance between protumor and antitumor immunity
- (2008) Suzanne Ostrand-Rosenberg CURRENT OPINION IN GENETICS & DEVELOPMENT
- Tumour immunity: effector response to tumour and role of the microenvironment
- (2008) Alberto Mantovani et al. LANCET
- A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years
- (2007) Bettina S. Nedergaard et al. GYNECOLOGIC ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started